Filing Details

Accession Number:
0001209191-14-040701
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-11 19:32:30
Reporting Period:
2014-06-09
Filing Date:
2014-06-11
Accepted Time:
2014-06-11 19:32:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1123979 Senomyx Inc SNMX Services-Commercial Physical & Biological Research (8731) 330843840
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1183721 A Stephen Block C/O Senomyx, Inc.
4767 Nexus Center Drive
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-09 100 $2.37 1,100 No 4 M Direct
Common Stock Disposition 2014-06-09 100 $8.17 1,000 No 4 S Direct
Common Stock Acquisiton 2014-06-10 14,900 $2.37 15,900 No 4 M Direct
Common Stock Disposition 2014-06-10 14,900 $8.21 1,000 No 4 S Direct
Common Stock Acquisiton 2014-06-10 13,750 $2.10 14,750 No 4 M Direct
Common Stock Disposition 2014-06-10 13,750 $8.21 1,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2014-06-09 100 $0.00 100 $2.37
Common Stock Stock option (right to buy) Disposition 2014-06-10 14,900 $0.00 14,900 $2.37
Common Stock Stock option (right to buy) Disposition 2014-06-10 13,750 $0.00 13,750 $2.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,900 2022-06-06 No 4 M Direct
0 2022-06-06 No 4 M Direct
1,250 2023-06-12 No 4 M Direct
Footnotes
  1. The weighted average sale price for the transaction reported was $8.2147, and the range of prices were between $8.17 and $8.285. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
  2. In addition to the 1,000 shares of common stock beneficially owned, the Reporting Person also holds outstanding options to purchase 108,632 shares of common stock
  3. The shares subject to the option are fully vested.
  4. The shares subject to the option vest monthly after the grant date of 6/13/2013 until fully vested on 6/13/2014.